XORTX Therapeutics (XRTX) Enterprise Value (2020 - 2026)
XORTX Therapeutics (XRTX) posted Enterprise Value of -$250275.0 for Q1 2026, up 71.05% on a QoQ basis from -$864514.0 in Q4 2025, and up 86.79% year-over-year from -$133984.1 in Q1 2025.
XORTX Therapeutics (XRTX) Enterprise Value (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Enterprise Value history runs 7 years deep, the most recent figure standing at -$250275.0 for Q1 2026.
- Quarterly Enterprise Value rose 86.79% year-over-year to -$250275.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$250275.0 (up 86.79% YoY) and the FY2025 annual result came in at -$864514.0, up 65.05% from the prior year.
- Enterprise Value was -$250275.0 for Q1 2026 at XORTX Therapeutics, up from -$864514.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$250275.0 in Q1 2026 and bottomed at -$12.2 million in Q1 2022.
- A 5-year average of -$4.9 million and a median of -$3.5 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value tumbled 134.84% — and 2026, when it soared 86.79%.
- XORTX Therapeutics' Enterprise Value stood at -$10.4 million in 2022, then jumped by 51.29% to -$5.1 million in 2023, then jumped by 51.2% to -$2.5 million in 2024, then soared by 65.05% to -$864514.0 in 2025, then jumped by 71.05% to -$250275.0 in 2026.
- Business Quant data shows XRTX's Enterprise Value at -$250275.0 in Q1 2026, -$864514.0 in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | XORTX Therapeutics | 2.91 Bn | 2.91 Bn | - | -250,275.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -250,275.00 |
| Dec 31, 2025 | -864,514.00 |
| Sep 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -1.90 Mn |
| Dec 31, 2024 | -2.47 Mn |
| Sep 30, 2024 | -2.30 Mn |
| Jun 30, 2024 | -3.08 Mn |
| Mar 31, 2024 | -3.84 Mn |
| Sep 30, 2023 | -5.07 Mn |
| Jun 30, 2023 | -6.16 Mn |
| Mar 31, 2023 | -7.91 Mn |
| Dec 31, 2022 | -10.41 Mn |
| Sep 30, 2022 | -9.32 Mn |
| Jun 30, 2022 | -10.53 Mn |
| Mar 31, 2022 | -12.24 Mn |
| Dec 31, 2021 | -14.96 Mn |
| Sep 30, 2021 | -3.97 Mn |
| Dec 31, 2020 | -131,374.22 |